Lonza and Sanquin Partner to Offer Specialized MAT Reagents for in vitro Pyrogen Testing
Lonza Sales AG, through its Bioscience Division, announced Thursday a strategic partnership with Sanquin Reagents B.V. for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test (MAT).